Chemical Structure (Aponvie 01)
Aponvie Emulsion
Product Images NDC 47426-401
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Aponvie (NDC 47426-401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Heron Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Aponvie 02)
This is a graph with two medication treatments: Aprepitant 40 mg and Ondansetron. The data displays the percentage of patients who have taken either medication over a span of 48 hours after treatment. The percentage of patients is shown on the y-axis ranging from 0% to 100%, and the x-axis shows the time in hours.*
Principal Display Panel (10 Vial Carton)
APONVIE is an injectable emulsion that comes in single-dose vials. Each vial contains 32mg of aprepitant in 44 mL of solution. It is intended for intravenous administration and must be refrigerated at 2°C to 8°C (36°F to 46°F) and should not be frozen. APONVIE is a registered trademark of Heron Therapeutics, Inc., and is used for the treatment of nausea and vomiting caused by chemotherapy. The recommended dosage should be determined by a physician and can be found in the prescribing information. The vials contain inactive ingredients like sucrose, egg lecithin, and soybean oil. Lot and manufacturer information is also provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
